Developing new DNA damage and repair inhibitors on the CLARIOstar Plus
- Company/University: Artios Pharma, UK
- Interviewee: Claire McWhirter
- Products used: CLARIOstar Plus
- Method: development and characterisation of new inhibitors, endpoint and kinetic fluorescence intensity assays, fluorescence polarisation, luminescence
